New lab device records cancer cells metastasizing on the microscopic level
the ONA take:
Current imaging technology can only provide a limited view of how cancer cells migrate to blood vessels and spread through the body. Improved imaging would give clinicians better insight into the metastasis process, which causes a majority of cancer-related mortality. The bloodstream provides a fast means of transport for cancer cells wishing to spread throughout the body.
Engineers based at Johns Hopkins’ Whiting School of Engineering and its Institute for NanoBioTechnology (INBT) developed a lab chip system that allows them to record the movement of cancer cells on the microscopic level. Early stages of metastasis were recreated on this chip, which includes an artificial blood vessel replicated via a three-dimensional collagen matrix. The material employed behaves similarly to healthy human tissue that surrounds tumors and is often the target of cancer metastases.
Investigators were able to record video of breast cancer cells moving through the matrix. Lead researcher, Andrew D. Wong, reported that his team was also able to obtain video footage of individual cancer cells pushing through the wall of an artificial blood vessel, a process that matches early metastasis.
This new artificial blood vessel and micro environment provides an ideal way to observe the minute details of metastasis, and can help shed insight into ways to stop or slow steps in the metastatic cascade.
A lab chip system allows you to record the movement of cancer cells on the microscopic level.
Johns Hopkins engineers have invented a lab device to give cancer researchers an unprecedented microscopic look at metastasis, the complex way that tumor cells spread through the body, causing more than 90 percent of cancer-related deaths. By shedding light on precisely how tumor cells travel, the device could uncover new ways to keep cancer in check.
The inventors, from the university's Whiting School of Engineering and its Institute for NanoBioTechnology (INBT), published details and images from their new system recently in the journal Cancer Research.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- CQGS Releases Standards for Surgical Care of Older Adults
- Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy
- Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|